Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Jan Klatt
Novartis Pharma AG
Basel, 4056
Switzerland
Contact
Novartis Pharma AG
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
161
TOTAL CITATIONS
5
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Erenumab Versus Topiramate for the Prevention of Migraine – A Randomised, Double-Blind, Active-Controlled Phase 4 Trial
Number of pages: 25
Posted: 04 Mar 2021
Uwe Reuter
,
Marc Ehrlich
,
Astrid Gendolla
,
Axel Heinze
, Jan Klatt,
Shihua Wen
,
Peggy Hours-Zesiger
,
Jaqueline Nickisch
,
Christian Hentschke
,
Christian Sieder
and
Monika Maier-Peuschel
Charité - Universitätsmedizin Berlin, Novartis Pharma GmbH, Praxis Gendolla, Kiel Migraine and Headache Centre, Novartis Pharma AG, Novartis International AG, Novartis Pharma AG, Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma GmbH and Novartis Pharma GmbH
Downloads
161
(464,454)
Citation
5
View PDF
Download
Abstract:
Feedback
